Price History
Feb 9, 2026 — Apr 4, 2026Investment Snapshot
- Trading 207% above Graham Number — above intrinsic value estimate
- Piotroski F-Score 7/9 — financially strong with improving fundamentals
- ROE of 15.6% — good return on equity
- Revenue growing at 29% annually
PACS GROUP, INC. (PACS) is a Healthcare company operating in Services-Skilled Nursing Care Facilities, listed on the NYSE , with a market capitalisation of $5.4 billion . Key value metrics: P/E ratio 36.9, P/B ratio 5.75, Piotroski F-Score 7 out of 9 (strong financial health) .
Value Score
Key Metrics
Current vs 5-Year Average
Based on 3 years of SEC filingsRevenue & Net Income
Financial Statements
| Metric | FY22 | FY23 | FY24 |
|---|---|---|---|
| Revenue | $X.XB | $X.XB | $X.XB |
| Gross Profit | $X.XB | $X.XB | $X.XB |
| Operating Income | $X.XB | $X.XB | $X.XB |
| Net Income | $X.XB | $X.XB | $X.XB |
| EBITDA | $X.XB | $X.XB | $X.XB |
| Total Assets | $X.XB | $X.XB | $X.XB |
| Total Liabilities | $X.XB | $X.XB | $X.XB |
PACS GROUP, INC. — Fundamental Analysis Summary
PACS GROUP, INC. (PACS) is currently trading 207% above its Graham Number of $11.28, suggesting the market price exceeds Benjamin Graham's intrinsic value estimate. The stock carries an elevated trailing P/E ratio of 36.9x.
On financial health, PACS shows a strong Piotroski F-Score of 7/9, indicating improving fundamentals across profitability, leverage, and efficiency, and solid return on equity of 15.6% (sector average: -19.8%), and manageable leverage with a debt-to-equity ratio of 0.37.
StockPik's composite Value Score for PACS is 62/100 — an above-average value rating. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
PACS shows revenue growing at 29% year-over-year, with earnings growing at 244%.
PACS pays a modest dividend yield of 0.6%.